Brief: Citius Oncology Announces $18 Million Concurrent Registered Direct Offering And Private Placement Priced At-The-Market Under Nasdaq Rules
09/12/2025 13:32
Dec 9 (Reuters) - Citius Oncology Inc CTOR.O: CITIUS ONCOLOGY ANNOUNCES $18 MILLION CONCURRENT REGISTERED DIRECT OFFERING AND PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES CITIUS ONCOLOGY INC - PROCEEDS SUPPORT LAUNCH OF LYMPHIR FOR CUTANEOUS T-CELL LYMPHOMA CITIUS ONCOLOGY INC - TO PURCHASE 1,284,404 SHARES OF COMMON STOCK AT $1.09 PER SHARE IN DIRECT OFFERING Source text: ID:nPn7TkLKKa Further company coverage: CTOR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Citius Oncology
See all newsCitius Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Citius Oncology Inc expected to post a loss of 5 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-AnaptysBio, Tesla, Intel
U.S. STOCKS ON THE MOVE-Dycom Industries, Robinhood, Brown-Forman
Citius rises as lymphoma drug shows benefit in patients before CAR-T therapy